Iterum Therapeutics PLC
NASDAQ:ITRM
Iterum Therapeutics PLC
Total Other Income
Iterum Therapeutics PLC
Total Other Income Peer Comparison
Competitive Total Other Income Analysis
Latest Figures & CAGR of Competitors
Company | Total Other Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Iterum Therapeutics PLC
NASDAQ:ITRM
|
Total Other Income
$82k
|
CAGR 3-Years
-27%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
N/A
|
|
Perrigo Company PLC
NYSE:PRGO
|
Total Other Income
$12.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-41%
|
CAGR 10-Years
N/A
|
|
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
|
Total Other Income
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
|
Total Other Income
$87k
|
CAGR 3-Years
-65%
|
CAGR 5-Years
-48%
|
CAGR 10-Years
N/A
|
|
G
|
GH Research PLC
NASDAQ:GHRS
|
Total Other Income
$3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Cosmo Pharmaceuticals NV
SIX:COPN
|
Total Other Income
-€118k
|
CAGR 3-Years
11%
|
CAGR 5-Years
22%
|
CAGR 10-Years
18%
|
See Also
What is Iterum Therapeutics PLC's Total Other Income?
Total Other Income
82k
USD
Based on the financial report for Dec 31, 2023, Iterum Therapeutics PLC's Total Other Income amounts to 82k USD.
What is Iterum Therapeutics PLC's Total Other Income growth rate?
Total Other Income CAGR 5Y
-27%
Over the last year, the Total Other Income growth was -84%. The average annual Total Other Income growth rates for Iterum Therapeutics PLC have been -27% over the past three years , -27% over the past five years .